Home › Funds › Merck & Co., Inc. › ALEC

Merck & Co., Inc. position in ALEC

ALECTOR INC · Health Care

Merck & Co., Inc. reported holding 3,545,719 shares of ALEC (ALECTOR INC) in its Q3 2026 13F filing — a position valued at US$6.6M, representing 0.80% of its reported portfolio and ranking #7 among its reported holdings. Merck & Co., Inc. has disclosed ALEC holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)3.55M sh
Reported value held$6.56M
Portfolio Weight0.80%
First reportedQ4 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Merck & Co., Inc.'s ALEC position evolved

Merck & Co., Inc. first disclosed a stake in ALEC in Q4 2024 at 3,545,719 shares (US$6.7M). The position peaked in Q3 2025 at 3,545,719 shares, worth US$10.5M. Across 8 filings, Merck & Co., Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,545,719 shares valued at US$6.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 3.55M $6.70M New
Q1 2025 3.55M $4.36M Hold
Q2 2025 3.55M $4.96M Hold
Q3 2025 3.55M $10.50M Hold
Q4 2025 3.55M $5.53M Hold
Q1 2026 3.55M $7.62M Hold
Q2 2026 3.55M $7.13M Hold
Q3 2026 3.55M $6.56M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALEC and 13F data

ALEC (ALECTOR INC) is a Health Care company. 27 other funds we track also report a position in ALEC — the largest reported positions include TCG Crossover Management, LLC (US$20.1M), Kynam Capital Management, LP (US$7.7M), Ikarian Capital, LLC (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALEC

All ALEC fund holders →

FAQ

How long has Merck & Co., Inc. held ALEC?

Merck & Co., Inc. has disclosed ALEC holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Merck & Co., Inc.'s current position in ALEC?

As of Q3 2026, Merck & Co., Inc. holds 3.55M shares of ALEC (ALECTOR INC), valued at $6.56M, representing 0.80% of its reported portfolio and ranking #7.

Has Merck & Co., Inc. been buying or selling ALEC?

In the latest 13F filing (Q3 2026), Merck & Co., Inc. held unchanged its position in ALEC. The position peaked in Q3 2025 at 3.55M shares.

Which other funds hold ALEC?

Other major institutional holders of ALEC include TCG Crossover Management, LLC, Kynam Capital Management, LP, Ikarian Capital, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.